Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Phenobarbital

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 51Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of May 25, 2022
    Enforcement Report - Week of May 25, 2022

    25 May 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-25-2022-1653460687.pdf

    FDA
    25 May 2022
    Share Share
    SPARC gets orphan drug designation for Phenobarbital but shares decline 5%
    SPARC gets orphan drug designation for Phenobarbital but shares decline 5%

    08 Oct 2019

    // MONEY CONTROL

    https://www.moneycontrol.com/news/business/stocks/sparc-gets-orphan-drug-designation-for-phenobarbital-but-shares-decline-5-4509041.html

    MONEY CONTROL
    08 Oct 2019
    Share Share
    Health Canada Issues Recall of Pharmascience`s Phenobarb 30mg Tablet
    Health Canada Issues Recall of Pharmascience`s Phenobarb 30mg Tablet

    02 Mar 2019

    // HEALTH CANADA

    https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-pharmasciences-phenobarb-30mg-tablet-1552020509.pdf

    HEALTH CANADA
    02 Mar 2019
    Share Share
    Enforcement Report - Week of August 30, 2017
    Enforcement Report - Week of August 30, 2017

    30 Aug 2017

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-30-2017-1504070345.pdf

    FDA
    30 Aug 2017
    Share Share
    FDA calls Truxton phenobarb, amitriptyline recalls Class I, II
    FDA calls Truxton phenobarb, amitriptyline recalls Class I, II

    23 Aug 2017

    // Joseph Keenan FIERCE PHARMA

    http://www.fiercepharma.com/manufacturing/fda-labels-ongoing-truxton-phenobarbital-and-amitriptyline-recalls-as-class-i-ii

    Joseph Keenan FIERCE PHARMA
    23 Aug 2017
    Share Share
    RedHill Announces US Commercialization Agreement Product Esomeprazole Strontium
    RedHill Announces US Commercialization Agreement Product Esomeprazole Strontium

    17 Aug 2017

    // GLOBENEWSWIRE

    https://globenewswire.com/news-release/2017/08/17/1087023/0/en/RedHill-Biopharma-Announces-U-S-Commercialization-Agreement-for-FDA-Approved-GI-Product-Esomeprazole-Strontium-Delayed-Release-Capsules.html

    GLOBENEWSWIRE
    17 Aug 2017
    Share Share